Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Margine, Irina ^a   Martinez Gil, Luis ^a   Chou, Yi ying ^a   Krammer, Florian ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; INSECT CELL; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; SURVIVAL; VIRUS IMMUNITY; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTERFERON-BETA; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; SF9 CELLS; SPODOPTERA; VACCINES, VIRUS-LIKE PARTICLE;

HEXAPODA; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 84870918223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051559     Document Type: Article

References (49)

1. Tosh PK, Jacobson RM, Poland GA, (2010) Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc 85: 257-273.
2. Nichol KL, (2008) Efficacy and effectiveness of influenza vaccination. Vaccine 26Suppl 4: D17-22.
3. Palese P, (2006) Making better influenza virus vaccines? Emerg Infect Dis 12: 61-65.
4. D'Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, et al. (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 8: 607-619.
5. Krammer F, Grabherr R, (2010) Alternative influenza vaccines made by insect cells. Trends Mol Med 16: 313-320.
6. Szécsi J, Boson B, Johnsson P, Dupeyrot-Lacas P, Matrosovich M, et al. (2006) Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses. Virol J 3: 70.
7. Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM, (2012) Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clin Vaccine Immunol 19: 128-139.
8. Wu CY, Yeh YC, Yang YC, Chou C, Liu MT, et al. (2010) Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS One 5: e9784.
9. López-Macías C (2012) Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother 8.
10. López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, et al. (2011) Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine 29: 7826-7834.
11. Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, et al. (2010) Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 45: 226-234.
12. Haynes J, Dokken L, Wiley J, Cawthon A, Bigger J, et al. (2009) Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27: 530-541.
13. Pushko P, Tumpey T, Bu F, Knell J, Robinson R, et al. (2005) Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23: 5751-5759.
14. Song JM, Choi CW, Kwon SO, Compans RW, Kang SM, et al. (2011) Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity. J Proteome Res 10: 3450-3459.
15. Easterbrook JD, Schwartzman LM, Gao J, Kash JC, Morens DM, et al. (2012) Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology 432: 39-44.
16. Latham T, Galarza J, (2001) Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 75: 6154-6165.
17. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1.
18. Hermida-Matsumoto L, Resh MD, (2000) Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 74: 8670-8679.
19. Hai R, Martínez-Sobrido L, Fraser KA, Ayllon J, García-Sastre A, et al. (2008) Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol 82: 10580-10590.
20. Krammer F, Nakowitsch S, Messner P, Palmberger D, Ferko B, et al. (2010) Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice. Biotechnol J 5: 17-23.
21. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 92: 7297-7301.
22. Krammer F, Margine I, Tan GS, Pica N, Krause JC, et al. (2012) A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. Plos One.
23. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS pathogens 7: e1002067.
24. Dinca L, Neuwirth S, Schulman J, Bona C, (1993) Induction of antihemagglutinin antibodies by polyclonal antiidiotype antibodies. Viral Immunol 6: 75-84.
25. Pica N, Hai R, Krammer F, Wang TT, Maamary J, et al. (2012) Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 109: 2573-2578.
26. Lowen AC, Steel J, Mubareka S, Carnero E, Garcia-Sastre A, et al. (2009) Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. Journal of virology 83: 2803-2818.
27. Wang TT, Tan GS, Hai R, Pica N, Petersen E, et al. (2010) Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6: e1000796.
28. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
29. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
30. Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, et al. (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A 105: 5986-5991.
31. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, et al. (2012) A pan-h1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol 86: 6179-6188.
32. Krammer F, Pica N, Hai R, Tan GS, Palese P (2012) Hemagglutinin stalk reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice. J Virol.
33. Nimmerjahn F, Ravetch JV, (2006) Fcgamma receptors: old friends and new family members. Immunity 24: 19-28.
34. Quan F, Huang C, Compans R, Kang S, (2007) Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81: 3514-3524.
35. Renegar KB, Small PA Jr, Boykins LG, Wright PF, (2004) Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. Journal of immunology 173: 1978-1986.
36. Guarino L (2001) Baculoviruses. eLS: John Wiley & Sons, Ltd.
37. Abe T, Matsuura Y, (2010) Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 10: 226-231.
38. Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C, (2007) Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369.
39. Abe T, Hemmi H, Miyamoto H, Moriishi K, Tamura S, et al. (2005) Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858.
40. Hu Y, (2008) Baculoviral vectors for gene delivery: a review. Curr Gene Ther 8: 54-65.
41. Toporovski R, Morrow MP, Weiner DB, (2010) Interferons as potential adjuvants in prophylactic vaccines. Expert Opin Biol Ther 10: 1489-1500.
42. Wickham TJ, Davis T, Granados RR, Hammer DA, Shuler ML, et al. (1991) Baculovirus defective interfering particles are responsible for variations in recombinant protein production as a function of multiplicity of infection. Biotechnol Lett July v. 13 (7): 483-488.
43. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, et al. (2003) Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171: 1133-1139.
44. Wang TT, Palese P, (2011) Biochemistry. Catching a moving target. Science 333: 834-835.
45. Khurana S, Wu J, Verma N, Verma S, Raghunandan R, et al. (2011) H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies in humans that preferentially bind to oligomeric form of influenza hemagglutinin. J Virol.
46. Tao P, Luo M, Zhu D, Qu S, Yang Z, et al. (2009) Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral Immunol 22: 273-281.
47. Bright R, Carter D, Daniluk S, Toapanta F, Ahmad A, et al. (2007) Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25: 3871-3878.
48. Kang SM, Yoo DG, Kim MC, Song JM, Park MK, et al. (2011) MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J Virol 85: 11391-11400.
49. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, et al. (2009) Baculovirus induces type I interferon production through toll-like receptor-dependent and-independent pathways in a cell-type-specific manner. J Virol 83: 7629-7640.